Found: 21
Select item for more details and to access through your institution.
Host-specific differences in top-expanded TCR clonotypes correlate with divergent outcomes of anti-PD-L1 treatment in responders versus non-responders.
- Published in:
- Frontiers in Immunology, 2023, v. 14, p. 01, doi. 10.3389/fimmu.2023.1100520
- By:
- Publication type:
- Article
Divergent outcomes of anti-PD-L1 treatment coupled with host-intrinsic differences in TCR repertoire and distinct T cell activation states in responding versus non-responding tumors.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 01, doi. 10.3389/fimmu.2022.992630
- By:
- Publication type:
- Article
TRAF2/3 deficient B cells resist DNA damage-induced apoptosis via NF-κB2/XIAP/cIAP2 axis and IAP antagonist sensitizes mutant lymphomas to chemotherapeutic drugs.
- Published in:
- Cell Death & Disease, 2023, v. 14, n. 9, p. 1, doi. 10.1038/s41419-023-06122-2
- By:
- Publication type:
- Article
Differential tumor immune microenvironment coupled with tumor progression or tumor eradication in HPV-antigen expressing squamous cell carcinoma (SCC) models.
- Published in:
- Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2024.1405318
- By:
- Publication type:
- Article
HDAC inhibitors overcome immunotherapy resistance in B-cell lymphoma.
- Published in:
- Protein & Cell, 2020, v. 11, n. 7, p. 472, doi. 10.1007/s13238-020-00694-x
- By:
- Publication type:
- Article
Deletion of p53 and Hyper-Activation of PIK3CA in Keratin-15+ Stem Cells Lead to the Development of Spontaneous Squamous Cell Carcinoma.
- Published in:
- International Journal of Molecular Sciences, 2020, v. 21, n. 18, p. 6585, doi. 10.3390/ijms21186585
- By:
- Publication type:
- Article
Mechanisms promoting translocations in editing and switching peripheral B cells.
- Published in:
- Nature, 2009, v. 460, n. 7252, p. 231, doi. 10.1038/nature08159
- By:
- Publication type:
- Article
Differential responses to immune checkpoint inhibitor dictated by pre-existing differential immune profiles in squamous cell carcinomas caused by same initial oncogenic drivers.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2022, v. 41, n. 1, p. 1, doi. 10.1186/s13046-022-02337-x
- By:
- Publication type:
- Article
Unexpected effects of different genetic backgrounds on identification of genomic rearrangements via whole-genome next generation sequencing.
- Published in:
- BMC Genomics, 2016, v. 17, p. 1, doi. 10.1186/s12864-016-3153-9
- By:
- Publication type:
- Article
The programmed death ligand 1 interactome demonstrates bidirectional signaling coordinating immune suppression and cancer progression in head and neck squamous cell carcinoma.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2023, v. 115, n. 11, p. 1392, doi. 10.1093/jnci/djad126
- By:
- Publication type:
- Article
Tumor immune microenvironment in head and neck cancers.
- Published in:
- Molecular Carcinogenesis, 2020, v. 59, n. 7, p. 766, doi. 10.1002/mc.23162
- By:
- Publication type:
- Article
Lessons learned from SMAD4 loss in squamous cell carcinomas.
- Published in:
- Molecular Carcinogenesis, 2019, v. 58, n. 9, p. 1648, doi. 10.1002/mc.23049
- By:
- Publication type:
- Article
Why responses to immune checkpoint inhibitors are heterogeneous in head and neck cancers: Contributions from tumor-intrinsic and hostintrinsic factors.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.995434
- By:
- Publication type:
- Article
CEACAM1 on activated NK cells inhibits NKG2 D-mediated cytolytic function and signaling.
- Published in:
- European Journal of Immunology, 2013, v. 43, n. 9, p. 2473, doi. 10.1002/eji.201242676
- By:
- Publication type:
- Article
FAK loss reduces BRAF<sup>V600E</sup>-induced ERK phosphorylation to promote intestinal stemness and cecal tumor formation.
- Published in:
- eLife, 2024, p. 1, doi. 10.7554/eLife.94605
- By:
- Publication type:
- Article
CDK4 deficiency promotes genomic instability and enhances Myc-driven lymphomagenesis.
- Published in:
- Journal of Clinical Investigation, 2014, v. 124, n. 4, p. 1672, doi. 10.1172/JCI63139
- By:
- Publication type:
- Article
Distinct immune microenvironment profiles of therapeutic responders emerge in combined TGFβ/PD-L1 blockade-treated squamous cell carcinoma.
- Published in:
- Communications Biology, 2021, v. 4, n. 1, p. 1, doi. 10.1038/s42003-021-02522-2
- By:
- Publication type:
- Article
Th2 Cells Are Associated with Tumor Recurrence Following Radiation.
- Published in:
- Cancers, 2024, v. 16, n. 8, p. 1586, doi. 10.3390/cancers16081586
- By:
- Publication type:
- Article
Combined deletion of Xrcc4 and Trp53 in mouse germinal center B cells leads to novel B cell lymphomas with clonal heterogeneity.
- Published in:
- Journal of Hematology & Oncology, 2016, v. 9, p. 1, doi. 10.1186/s13045-015-0230-5
- By:
- Publication type:
- Article
How the Signaling Crosstalk of B Cell Receptor (BCR) and Co-Receptors Regulates Antibody Class Switch Recombination: A New Perspective of Checkpoints of BCR Signaling.
- Published in:
- Frontiers in Immunology, 2021, v. 11, p. N.PAG, doi. 10.3389/fimmu.2021.663443
- By:
- Publication type:
- Article
Why the Outcome of Anti‐Tumor Immune Responses is Heterogeneous: A Novel Idea in the Context of Immunological Heterogeneity in Cancers.
- Published in:
- BioEssays, 2020, v. 42, n. 10, p. 1, doi. 10.1002/bies.202000024
- By:
- Publication type:
- Article